BioSpace News Archive

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a first generic version of Revlimid®1 (lenalidomide capsules), in 5mg, 10mg, 15mg, and 25mg strengths, in the United States.

Alchemab Therapeutics and Medicines Discovery Catapult Announce Extension of Collaboration to Study Disease Modifying Therapies in Alzheimer’s Disease and Frontotemporal Dementia.

Element Biosciences Inc., developer of a new and disruptive DNA sequencing platform, is hosting a virtual event to launch its AVITI benchtop sequencer that offers unprecedented performance, cost and flexibility.

Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced that members of the Company’s leadership team will be participating at the following upcoming investor conferences in March.

Curebase, a company committed to democratizing access to clinical studies, and Blue Note Therapeutics, a prescription digital therapeutics (PDT) company dedicated to easing the burden of cancer and improving outcomes, have announced a collaboration on a virtual clinical trial that will study the effectiveness of two digital therapeutics.

Blade Therapeutics, Inc. announced that Wendye Robbins, M.D., president and CEO, will present at two investor conferences in March.

AM-Pharma B.V. today announced two presentations at the 27th International Conference on Advances in Critical Care Nephrology in San Diego, CA.

VBI Vaccines Inc. today announced financial results for the fourth quarter and twelve months ended December 31, 2021.

Horizon Therapeutics plc Announces FDA Has Granted Priority Review of the Supplemental Biologics License Application (sBLA) for the Concomitant Use of KRYSTEXXA ® (pegloticase injection) Plus Methotrexate for People Living With Uncontrolled Gout.

Alpine Immune Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on its NEON-2 trial evaluating davoceticept.